Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: The T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign was previously reported as a diagnostic indicator of diffuse astrocytoma, isocitrate dehydrogenase-mutant, and 1p/19q noncodeletion. Subsequently, it was reported that the same findings were observed in diffuse intrinsic pontine glioma (DIPG). We investigated the clinical significance of T2-FLAIR mismatch sign in DIPG.
Methods: Twenty-one patients with DIPG (Male: Female = 12:9) were treated at our institute between 2004 and 2019. All patients were treated with local radiotherapy of 54 Gy/30 fractions. The positive T2-FLAIR mismatch sign was defined if it fulfilled the following criteria: (1) T2-FLAIR mismatch volume was >50% of T2 high volume at nonenhanced area, (2) the FLAIR low lesion is not associated with gadolinium enhancement (inside of enhancement or just outside of enhancement defined as edema), and (3) signal-intensity of FLAIR lowest lesion at tumor is lower than the normal cerebellar cortex.
Results: In our patient series, T2-FLAIR mismatch sign was found in 5 out of 21 patients. Objective response rate of radiotherapy was 100% in patients positive for T2-FLAIR mismatch, while it was 25.0% in patients negative for T2-FLAIR mismatch, and this difference was statistically significant (p < 0.01, Fisher's exact test). In patients under the age of 18-years, T2-FLAIR mismatch positive had a slightly better prognosis (p < 0.05, Wilcoxon test).
Conclusion: T2-FLAIR mismatch sign in DIPG may be an indicator for better response to radiotherapy and a better prognostic factor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000513360 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High-grade astrocytoma with piloid features resected with an exoscopic supracerebellar infratentorial approach: illustrative case.
J Neurosurg Case Lessons
September 2025
Department of Neurosurgery, Fleming Neuroscience Institute, Allentown, Pennsylvania.
Background: High-grade astrocytoma with piloid features (HGAP) was recently added to the WHO 2021 CNS classification system among the group of circumscribed astrocytic gliomas. These tumors present with high-grade piloid histology with similarities to glioblastoma. HGAPs in the pineal region become particularly challenging due to its deep location and proximity to deep venous structures, the midbrain, and the thalamus.
View Article and Find Full Text PDFDifferentiation of Molecular Glioblastomas and Lower-grade Diffuse Astrocytomas Using MRI Perfusion and Diffusion Parameters.
Clin Neuroradiol
August 2025
Department of Neuroradiology, Karolinska University Hospital, Eugeniavägen 3, 17176, Stockholm, Sweden.
Background And Purpose: Molecular glioblastomas are challenging to distinguish from lower-grade diffuse astrocytomas (grades 2-3) without T2/T2 FLAIR mismatch, when assessed on T1-gadolinium and T2/T2 FLAIR MRI. This study aimed to evaluate the performance of the ADC from diffusion-weighted imaging and the relative CBV from DSC perfusion imaging in differentiating molecular glioblastomas from lower-grade diffuse astrocytomas.
Materials And Methods: Fourteen patients with molecular glioblastomas (defined as isocitrate dehydrogenase wildtype (IDH-wt), exhibiting one or more of the following: telomerase reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) gene amplification, or +7/-10 chromosomal alterations, but without microvascular proliferation or necrosis) and thirteen patients with lower-grade diffuse astrocytomas (IDH-mutated or not elsewhere classified, grades 2-3) were included.
Phenotype augmentation using generative AI for isocitrate dehydrogenase mutation prediction in glioma.
Sci Rep
August 2025
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
This study investigated the effects of feature augmentation, which uses generated images with specific imaging features, on the performance of isocitrate dehydrogenase (IDH) mutation prediction models in gliomas. A total of 598 patients were included from our institution (310 training, 152 internal test) and the Cancer Genome Atlas (136 external test). Score-based diffusion models were used to generate T2-weighted, FLAIR, and contrast-enhanced T1-weighted image triplets.
View Article and Find Full Text PDFAdvanced imaging of IDH-mutant gliomas: Precision in diagnosis and management.
Adv Cancer Res
July 2025
Neuroradiology Service, Department of Radiology, Memorial Sloan Kettering, New York, NY, United States. Electronic address:
Advancements in imaging techniques and analyses have evolved in parallel with advancements in precision oncology and the transformative changes in glioma diagnosis and management. This chapter explores the pivotal roles of modern qualitative and quantitative imaging in characterizing gliomas, particularly low-grade gliomas (LGGs). Key topics include the integration of standard imaging biomarkers (e.
View Article and Find Full Text PDFPediatric-type diffuse low-grade gliomas with MYB alterations: Neuroimaging of the Diffuse astrocytomas, or -altered.
AJNR Am J Neuroradiol
June 2025
From the Neuroradiology Unit, Department of Diagnostic and Interventional Radiology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy (FC, GM). Diagnostic and Interventional Neuroradiology, Neuroradiological Reference Center for the HIT-Studies of the GPOH, Faculty of Medicine, Uni
Background And Purpose: Diffuse astrocytoma, MYB or MYBL1-altered is a new tumor type in the family of Pediatric-type diffuse low-grade gliomas and genetically related to angiocentric glioma. Imaging features of Diffuse astrocytoma, MYB or MYBL1-altered are less well known. During our clinical work, we identified a relatively characteristic imaging pattern in a subset of our patients consisting of a large, diffuse hemispheric tumor with displaced central vessels which we termed the "fireworks sign".
View Article and Find Full Text PDF